Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avodart with Laser TURP for Benign Prostatic Hyperplasia
NCT00431626Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- Oct 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by Northwestern University. Started Oct 2006; status: terminated.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00431626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431626.